TOPLINE: New-onset atrial fibrillation (AF) is associated with a substantially higher risk for all-cause dementia in patients with type 2 diabetes (T2D). METHODOLOGY: Studies suggest a...
Despite secondary prevention with oral anticoagulation (OAC), the risk for recurrent ischemic stroke (IS) and mortality is high in patients with atrial fibrillation (AF). However, OAC...
Replacing meat with plant-based meat alternatives (PBMAs) can improve cardiovascular disease risk factors, including low-density lipoprotein cholesterol (LDL-C), a review of randomized controlled trials suggested. Long-term...
SAN DIEGO, California — Researchers are unraveling the complex relationship between cardiovascular (CV)- and stroke-related outcomes in migraine with, and without, aura. Early results of one...
TOPLINE: A new analysis showed that preeclampsia is associated with an increased risk for young-onset dementia. METHODOLOGY: Researchers analyzed data from the French Conception study, a...
This transcript has been edited for clarity. Dear colleagues, I’m Christoph Diener from the University Duisburg-Essen. In this month’s video, I would like to discuss eight...
Although elderly patients with dementia have similar rates of colonoscopy-related complications as patients without dementia, they have higher rates of other non-procedural complications, according to a...
BOSTON — Patients who have had a stroke are thought to be at a higher risk for another one, but oral anticoagulation with edoxaban led to...
When combined with clinical scores, a “game-changing” blood test can expedite the diagnosis and treatment of large vessel occlusion (LVO) stroke, potentially saving many lives, new...
BASEL, Switzerland — Although thrombectomy has been shown to be beneficial in patients with large-core ischemic stroke, a new analysis suggests that patients with the greatest...
In patients with acute ischemic stroke and elevated high-sensitivity cardiac troponin (hs-cTn), dynamic changes in hs-cTn are not helpful in identifying myocardial infarction (MI) or distinguishing...
BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of...